Clinical trials
Immunoblastic Lymphadenopathy trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Huijing Wu | 1 |
| Ou Bai, MD/PHD | 1 |
| Peking Union Medical College Hospital | 1 |
| Qingdao University | 1 |
| Shandong Provincial Hospital | 1 |
| Sun Yat-sen University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Zhejiang Cancer Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 14 |
| Enteropathy-Associated T-Cell Lymphoma | 4 |
| Lymphoma, Extranodal NK-T-Cell | 4 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Lymphoma, T-Cell | 4 |
| Hodgkin Disease | 2 |
| Lymphoma | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, T-Cell, Peripheral | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.